OSK-1 polypeptide toxin (The Australian National University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameOSK-1 polypeptide toxin (The Australian National University)
Drug Alias NameKv1.3 potassium channel inhibitors (The Australian National University)
ClassificationBiologics > Protein drugs > ToxinBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVoltage-gated potassium channel subunit Kv1.3 blockers
TargetsVoltage-gated potassium channel subunit Kv1.3
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAustralian National University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAustralian National University
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A